Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
97,650,325
-
Share change
-
-12,587,435
-
Total reported value
-
$169,904,538
-
Put/Call ratio
-
157%
-
Price per share
-
$1.74
-
Number of holders
-
129
-
Value change
-
-$22,327,629
-
Number of buys
-
50
-
Number of sells
-
55
Institutional Holders of SYNERGY PHARMACEUTICALS DEL - COM NEW (SGYPQ) as of Q2 2018
As of 30 Jun 2018,
SYNERGY PHARMACEUTICALS DEL - COM NEW (SGYPQ) was held by
129 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
97,650,325 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Nantahala Capital Management, LLC, NORTHERN TRUST CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, Hikari Power Ltd, JPMORGAN CHASE & CO, and KINGDON CAPITAL MANAGEMENT, L.L.C..
This page lists
129
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.